Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
MCL1 overexpression
i
Other names:
MCL1, MCL1 Apoptosis Regulator BCL2 Family Member, Induced Myeloid Leukemia Cell Differentiation Protein Mcl-1, Myeloid Cell Leukemia Sequence 1 (BCL2-Related), MCL1 BCL2 Family Apoptosis Regulator, Bcl-2-Related Protein EAT/Mcl1, Myeloid Cell Leukemia 1, Bcl-2-Like Protein 3, Bcl2-L-3, Mcl1/EAT, BCL2L3, BCL2 Family Apoptosis Regulator, Myeloid Cell Leukemia ES, MCL1-ES, MCL1L, MCL1S, Mcl-1, EAT, TM
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
4170
Related biomarkers:
Expression
Mutation
CNA
Others
‹
MCL1 amplification (3)
MCL1 amplification (3)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
MCL1 overexpression
Chronic Lymphocytic Leukemia
MCL1 overexpression
Chronic Lymphocytic Leukemia
venetoclax
Resistant: C3 – Early Trials
venetoclax
Resistant
:
C3
venetoclax
Resistant: C3 – Early Trials
venetoclax
Resistant
:
C3
MCL1 overexpression
Multiple Myeloma
MCL1 overexpression
Multiple Myeloma
venetoclax
Resistant: D – Preclinical
venetoclax
Resistant
:
D
venetoclax
Resistant: D – Preclinical
venetoclax
Resistant
:
D
MCL1 overexpression
Multiple Myeloma
MCL1 overexpression
Multiple Myeloma
venetoclax
Resistant: D – Preclinical
venetoclax
Resistant
:
D
venetoclax
Resistant: D – Preclinical
venetoclax
Resistant
:
D
MCL1 overexpression
Acute Myelogenous Leukemia
MCL1 overexpression
Acute Myelogenous Leukemia
venetoclax + ONO-7475
Sensitive: D – Preclinical
venetoclax + ONO-7475
Sensitive
:
D
venetoclax + ONO-7475
Sensitive: D – Preclinical
venetoclax + ONO-7475
Sensitive
:
D
MCL1 overexpression
Acute Myelogenous Leukemia
MCL1 overexpression
Acute Myelogenous Leukemia
venetoclax + INCB59872
Sensitive: D – Preclinical
venetoclax + INCB59872
Sensitive
:
D
venetoclax + INCB59872
Sensitive: D – Preclinical
venetoclax + INCB59872
Sensitive
:
D
MCL1 overexpression
Colorectal Cancer
MCL1 overexpression
Colorectal Cancer
APG1244 + MCL1 inhibitor
Sensitive: D – Preclinical
APG1244 + MCL1 inhibitor
Sensitive
:
D
APG1244 + MCL1 inhibitor
Sensitive: D – Preclinical
APG1244 + MCL1 inhibitor
Sensitive
:
D
MCL1 overexpression
Colorectal Cancer
MCL1 overexpression
Colorectal Cancer
APG1244
Resistant: D – Preclinical
APG1244
Resistant
:
D
APG1244
Resistant: D – Preclinical
APG1244
Resistant
:
D
MCL1 overexpression
Mantle Cell Lymphoma
MCL1 overexpression
Mantle Cell Lymphoma
venetoclax + trametinib
Resistant: D – Preclinical
venetoclax + trametinib
Resistant
:
D
venetoclax + trametinib
Resistant: D – Preclinical
venetoclax + trametinib
Resistant
:
D
MCL1 overexpression
Multiple Myeloma
MCL1 overexpression
Multiple Myeloma
venetoclax + trametinib
Resistant: D – Preclinical
venetoclax + trametinib
Resistant
:
D
venetoclax + trametinib
Resistant: D – Preclinical
venetoclax + trametinib
Resistant
:
D
MCL1 overexpression
Chronic Lymphocytic Leukemia
MCL1 overexpression
Chronic Lymphocytic Leukemia
venetoclax + trametinib
Resistant: D – Preclinical
venetoclax + trametinib
Resistant
:
D
venetoclax + trametinib
Resistant: D – Preclinical
venetoclax + trametinib
Resistant
:
D
MCL1 overexpression
Acute Myelogenous Leukemia
MCL1 overexpression
Acute Myelogenous Leukemia
ME-344
Sensitive: D – Preclinical
ME-344
Sensitive
:
D
ME-344
Sensitive: D – Preclinical
ME-344
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.